Drug Margins Could Be Dampened By Medicare Drug Benefit - IMS
Executive Summary
The prosperity of the prescription drug market could be challenged by passage of a Medicare drug benefit, IMS Health VP-Supplier Relations Douglas Long said at the Pharmaceutical Care Management Association annual meeting in Tucson, Ariz. Oct. 17.